Bell Bank’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $201K | Buy |
+560
| New | +$171K | 0.01% | 192 |
|
|
2026
Q1 | – | Sell |
-774
| Closed | -$213K | – | 203 |
|
|
2025
Q4 | $213K | Hold |
774
| – | – | 0.01% | 186 |
|
|
2025
Q3 | $203K | Buy |
+774
| New | +$188K | 0.01% | 195 |
|
|
2025
Q2 | – | Sell |
-897
| Closed | -$201K | – | 204 |
|
|
2025
Q1 | $201K | Sell |
897
-2,827
| -76% | -$779K | 0.01% | 183 |
|
|
2024
Q4 | $1.22M | Sell |
3,724
-231
| -6% | -$72.7K | 0.09% | 85 |
|
|
2024
Q3 | $1.19M | Buy |
3,955
+176
| +5% | +$53.9K | 0.14% | 86 |
|
|
2024
Q2 | $1.24M | Sell |
3,779
-800
| -17% | -$283K | 0.1% | 78 |
|
|
2024
Q1 | $1.81M | Sell |
4,579
-513
| -10% | -$190K | 0.16% | 65 |
|
|
2023
Q4 | $1.79M | Sell |
5,092
-477
| -9% | -$169K | 0.17% | 66 |
|
|
2023
Q3 | $2.09M | Sell |
5,569
-236
| -4% | -$91.3K | 0.23% | 58 |
|
|
2023
Q2 | $2.22M | Sell |
5,805
-305
| -5% | -$109K | 0.24% | 56 |
|
|
2023
Q1 | $2.12M | Sell |
6,110
-79
| -1% | -$23.1K | 0.22% | 57 |
|
|
2022
Q4 | $1.46M | Sell |
6,189
-525
| -8% | -$124K | 0.17% | 78 |
|
|
2022
Q3 | $1.65M | Sell |
6,714
-19
| -0.3% | -$5.79K | 0.21% | 64 |
|
|
2022
Q2 | $2.04M | Buy |
6,733
+397
| +6% | +$129K | 0.24% | 57 |
|
|
2022
Q1 | $2.6M | Buy |
6,336
+441
| +7% | +$173K | 0.29% | 52 |
|
|
2021
Q4 | $2.77M | Buy |
5,895
+381
| +7% | +$164K | 0.32% | 52 |
|
|
2021
Q3 | $2.34M | Buy |
5,514
+288
| +6% | +$121K | 0.29% | 51 |
|
|
2021
Q2 | $1.88M | Buy |
5,226
+45
| +0.9% | +$14.9K | 0.25% | 54 |
|
|
2021
Q1 | $1.46M | Buy |
5,181
+82
| +2% | +$23.5K | 0.21% | 66 |
|
|
2020
Q4 | $1.45M | Buy |
5,099
+13
| +0.3% | +$3.65K | 0.22% | 59 |
|
|
2020
Q3 | $1.4M | Sell |
5,086
-1,025
| -17% | -$271K | 0.25% | 57 |
|
|
2020
Q2 | $1.39M | Sell |
6,111
-60
| -1% | -$11.8K | 0.26% | 54 |
|
|
2020
Q1 | $940K | Buy |
6,171
+41
| +0.7% | +$6.31K | 0.2% | 61 |
|
|
2019
Q4 | $922K | Buy |
6,130
+86
| +1% | +$12.5K | 0.17% | 72 |
|
|
2019
Q3 | $857K | Sell |
6,044
-73
| -1% | -$10.1K | 0.16% | 70 |
|
|
2019
Q2 | $766K | Sell |
6,117
-175
| -3% | -$20.7K | 0.17% | 73 |
|
|
2019
Q1 | $693K | Sell |
6,292
-236
| -4% | -$24.5K | 0.19% | 73 |
|
|
2018
Q4 | $640K | Buy |
6,528
+1,735
| +36% | +$188K | 0.2% | 75 |
|
|
2018
Q3 | $592K | Buy |
4,793
+734
| +18% | +$82.3K | 0.18% | 91 |
|
|
2018
Q2 | $403K | Buy |
4,059
+703
| +21% | +$64.7K | 0.12% | 108 |
|
|
2018
Q1 | $296K | Buy |
3,356
+222
| +7% | +$20.8K | 0.09% | 123 |
|
|
2017
Q4 | $309K | Sell |
3,134
-5
| -0.2% | -$490 | 0.09% | 113 |
|
|
2017
Q3 | $302K | Sell |
3,139
-38
| -1% | -$3.44K | 0.09% | 106 |
|
|
2017
Q2 | $300K | Buy |
+3,177
| New | +$292K | 0.11% | 106 |
|
Other funds holding WST
RP
SIM
GWI
MCG
YCM
BZWA
WA
Bell Bank's WST Position: Q2 2026 in Review
Bell Bank opened a new position in West Pharmaceutical (WST) in Q2 2026: 560 shares worth $201K. The stake represents 0.01% of the portfolio and ranks #192 among its holdings. This is a return to the name: Bell Bank previously reported a position in WST as recently as Q4 2025.
Bell Bank first reported a position in WST in Q2 2017 and has held it in 35 quarters since. The position peaked at $2.77M in Q4 2021. 111 funds tracked by Wall St. Rank hold WST as of Q2 2026.
- Bell Bank held 560 shares of West Pharmaceutical worth $201K as of Q2 2026.
- West Pharmaceutical was a new Bell Bank position in Q2 2026.
- West Pharmaceutical made up 0.01% of Bell Bank's portfolio in Q2 2026, its #192 holding.
- Bell Bank first reported a position in West Pharmaceutical in Q2 2017 and has held it in 35 quarters since.
- Bell Bank's West Pharmaceutical position peaked at $2.77M in Q4 2021.
- 111 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.
Based on Bell Bank's 13F filing for Q2 2026, filed 16 Jul 2026.